Key result
Essential hypertension is linked to ~14% higher arterial stiffness and increased cognitive impairment.
Why the study?
Arterial hypertension is linked to vascular aging and cognitive decline, but the clinical significance of anti-NR2/GluN2 antibodies related to neuronal-ischemic injury requires clarification.
Cross-Sectional (n=175)
No
Arterial stiffness and NR2 antibodies are elevated in patients with essential hypertension and are associated with cognitive impairment, suggesting a link between hypertensive vascular aging and neurovascular injury.
Arterial stiffness associates with cognitive impairment in hypertension; hypothesis-generating for anti-NR2 mechanisms, requiring longitudinal studies before clinical relevance.
Background: Arterial hypertension (HTN) is associated with accelerated vascular aging, cerebral microvascular injury, and cognitive decline. Anti-NR2/GluN2 (NR2) antibodies may be related to N-methyl-D-aspartate receptor (NMDAR)-mediated neuronal-ischemic injury, although their clinical significance in HTN requires further clarification. Objective: The aim of this study was to evaluate cross-sectional associations between arterial stiffness assessed by the cardio-ankle vascular index (CAVI), serum NR2 antibody levels, and cognitive performance assessed by the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) in patients with essential HTN and controls. Methods: This single-center study included 175 adults aged 40–70 years: 128 patients with essential HTN and 47 controls. The median age was 58 [54; 66] years in the HTN group and 55 [47; 62] years in controls (p = 0.06). Men accounted for 52 patients (40.6%) in the HTN group and 14 participants (30.0%) in the control group (p = 0.22). Arterial stiffness was assessed using CAVI. Serum NR2 antibody levels were measured by enzyme-linked immunosorbent assay. Cognitive status was evaluated using MoCA and MMSE. Between-group comparisons, correlation analysis, and exploratory classification modeling were performed. Results: Patients with HTN had higher CAVI values than controls (8.3 [7.3; 9.4] vs. 7.3 [6.9; 7.9]; p = 0.001). Cognitive impairment was more frequent in hypertensive patients by both MoCA (52.3% vs. 27.7%; p = 0.003) and MMSE (48.7% vs. 28.3%; p = 0.01). NR2 antibody levels were higher in HTN (1.6 [1.15; 2.62] vs. 1.33 [1.02; 1.84] ng/mL; p = 0.03). CAVI inversely correlated with MoCA and MMSE scores. Conclusions: CAVI was higher in patients with HTN and showed modest inverse associations with cognitive scores. NR2 antibody levels were also higher in HTN; however, their relationship with cognitive impairment should be interpreted as exploratory and hypothesis-generating. Further longitudinal studies with neuroimaging are required to determine the clinical and prognostic significance of these findings.
No takes yet. Share an insight, caveat, or question.
Safronova et al. (2026) conducted a cross-sectional in Essential arterial hypertension (n=175). Essential arterial hypertension vs. Healthy controls was evaluated on Cardio-ankle vascular index (CAVI) (p=0.001). Patients with essential hypertension had significantly higher arterial stiffness (median CAVI 8.3 vs 7.3) and more frequent cognitive impairment than healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: